In the News
Vertex hepatitis C drug helps the hard-to-treat - BusinessWeek
Biomed Middle East
Vertex hepatitis C drug helps the hard-to-treat
BusinessWeek
Vertex Pharmaceuticals Inc. said Tuesday that a late-stage clinical trial showed its hepatitis C drug candidate telaprevir proved effective for patients who ...
Vertex Maintains Lead Over Merck In Hepatitis CForbes (blog)
65% of People Whose Prior Treatment for Hepatitis C Was Unsuccessful Achieved ...MarketWatch (press release)
Vertex Cures Hard-to-Treat Hep C PatientsTheStreet.com
Xconomy -RTT News
all 33 news articles »
Categories: In the News
Bristol's Smart Buy - Forbes (blog)
Providence Eyewitness News
Bristol's Smart Buy
Forbes (blog)
It helps Bristol-Myers Squibb play in the emerging hepatitis C market by giving the company full control of the drug the two firms were developing together. ...
Bristol-Myers Will Buy ZymoGenetics for $885 MillionBloomberg
Bristol-Myers Squibb to Acquire ZymoGeneticsMarketWatch (press release)
Bristol-Myers Pays Up for ZymoGeneticsTheStreet.com
Northwest innovation
all 297 news articles »
Categories: In the News
Barclays, Oracle, Idenix Are Big Movers - ABC News
Barclays, Oracle, Idenix Are Big Movers
ABC News
The biopharmaceutical said the FDA has placed testing of two potential Hepatitis C drugs on hold because of safety concerns. A BMO analyst expects more ...
and more »
Categories: In the News
65% of People Whose Prior Treatment for Hepatitis C Was Unsuccessful Achieved ... - MarketWatch (press release)
65% of People Whose Prior Treatment for Hepatitis C Was Unsuccessful Achieved ...
MarketWatch (press release)
REALIZE enrolled three groups of patients with genotype 1 hepatitis C who had undergone at least one prior treatment course with pegylated-interferon and ...
Categories: In the News
Vertex Nails Third Big Trial With Hepatitis C Drug, In Toughest Patients to Treat - Xconomy
Vertex Nails Third Big Trial With Hepatitis C Drug, In Toughest Patients to Treat
Xconomy
“The Realize data represent a major milestone in the development of new treatments for hepatitis C,” Stefan Zeuzem, a professor of medicine at the JW Goethe ...
Categories: In the News
Idenix hep C drugs on clinical hold; shares plummet - Reuters
RTT News
Idenix hep C drugs on clinical hold; shares plummet
Reuters
O) said US health regulators halted all trials of two of its experimental hepatitis C drugs on safety concerns, putting the breaks on a potential ...
Idenix: Two Hep C Drugs on Clinical HoldTheStreet.com
Idenix Shares Plunge As FDA Puts Hepatitis C Drugs On Clinical Hold - UpdateRTT News
FDA halts Idenix Hep C drug targets on safety concernsMass High Tech
FierceBiotech -Capital.gr (press release) -Bloomberg
all 64 news articles »
Categories: In the News
Vertex Cures Hard-to-Treat Hep C Patients - TheStreet.com
Vertex Cures Hard-to-Treat Hep C Patients
TheStreet.com
By comparison, only 17% of these hard-to-treat hepatitis C patients were cured after being treated again with the current standard of care -- long-acting ...
Categories: In the News
Mayo Clinic Letter Leaves Patient Terrified - WJXT Jacksonville
Mayo Clinic Letter Leaves Patient Terrified
WJXT Jacksonville
A man who is one of 3209 patients who may be at risk of hepatitis C while at the Mayo Clinic said he's dealing with the very personal, private health matter ...
HSE STILL CALLING FOR GALWAY PATIENTS TO RECEIVE HEPATITIS TESTGalway News
all 2 news articles »
Categories: In the News
China Sky One, Idenix: Volume Movers - TheStreet.com
China Sky One, Idenix: Volume Movers
TheStreet.com
... notice from Food and Drug Administration that programs for advanced hepatitis C drug candidates IDX184 and IDX320 have been placed on clinical hold. ...
and more »
Categories: In the News
Idenix shares slump on hepatitis C drug comments - Reuters
Idenix shares slump on hepatitis C drug comments
Reuters
... notice from the Food and Drug Administration that two of its experimental hepatitis C treatments have been put on clinical hold due to safety issues. ...
Categories: In the News
New Patents Expand Coverage for Imaging and Therapeutic Applications of ... - MarketWatch (press release)
New Patents Expand Coverage for Imaging and Therapeutic Applications of ...
MarketWatch (press release)
The company is pursuing multiple clinical programs in cancer and hepatitis C virus infection with its lead product candidate bavituximab and novel brain ...
and more »
Categories: In the News
First partnership conference on fight against hepatitis B and C - Europolitics.info
First partnership conference on fight against hepatitis B and C
Europolitics.info
The idea of setting up an international conference on hepatitis B and hepatitis C, which had encouraged ...
and more »
Categories: In the News
Bon Secours opens liver disease clinic - Daily Press
Bon Secours opens liver disease clinic
Daily Press
Now, there's a new liver specialist in Newport News to treat hepatitis C, fatty liver disease and other conditions of the liver. ...
Categories: In the News
Hepatitis Therapeutics Market to 2016 - Strong Hepatitis-C Vaccine Pipeline ... - PressZoom (press release)
Hepatitis Therapeutics Market to 2016 - Strong Hepatitis-C Vaccine Pipeline ...
PressZoom (press release)
By 2016, the global hepatitis market is estimated to reach $5977m, indicating a CAGR of 9% between 2009 and 2016. The hepatitis A and hepatitis C markets ...
and more »
Categories: In the News
One in 10 at risk of Hep C ignores test call - Irish Independent
One in 10 at risk of Hep C ignores test call
Irish Independent
By Eilish O'Regan Health Correspondent More than one in 10 of the hundreds of former hospital patients exposed to the potentially fatal virus hepatitis C ...
and more »
Categories: In the News
Potent New Hepatitis C Drug : Clinical Trials Moving Forward - Ivanhoe
Potent New Hepatitis C Drug : Clinical Trials Moving Forward
Ivanhoe
(Ivanhoe Newswire) - The first clinical trials on a new investigational drug being developed to treat infections caused by Hepatitis C virus have been ...
and more »
Categories: In the News
FDA cautions consumers about Estrella Family Creamery cheeses
The U.S. Food and Drug Administration is warning consumers to discard cheeses from Estrella Family Creamery of Montesano, Wash., because they may be contaminated with Listeria monocytogenes. Environmental samples and one product sample collected by the FDA during an August 2010 inspection at the facility have tested positive for L. mono.
Categories: In the News
Animal rights groups face off with scientists over fate of chimps - Los Angeles Times (blog)
Los Angeles Times
Animal rights groups face off with scientists over fate of chimps
Los Angeles Times (blog)
John L. VandeBerg, director of the San Antonio primate center, says the chimpanzees are needed to test potential vaccines for diseases, such as hepatitis C ...
Will Aging Chimps Get to Retire, or Face Medical Research?New York Times
Holloman chimps heading for new lab tests in TexasThe New Mexico Independent
all 11 news articles »
Categories: In the News
Animal rights groups face off with scientists over fate of chimps - Los Angeles Times (blog)
Los Angeles Times (blog)
Animal rights groups face off with scientists over fate of chimps
Los Angeles Times (blog)
John L. VandeBerg, director of the San Antonio primate center, says the chimpanzees are needed to test potential vaccines for diseases, such as hepatitis C ...
and more »
Categories: In the News
Comedian Robert Schimmel has died - Monsters and Critics.com
Why Fame
Comedian Robert Schimmel has died
Monsters and Critics.com
The comedian has suffered several health setbacks, including cirrhosis of the liver from a bad blood transfusion which infected him with Hepatitis C, ...
Robert Schimmel Dead at 60 from Car Accident InjuriesCMR
Robert Schimmel, Comic, Dies at 60New York Times
Comic Robert Schimmel, 60, has died of injuries sustained in an auto accident ...Television Week (blog)
Kansas City Star -Zap2it.com (blog)
all 407 news articles »
Categories: In the News
© Lloyd Wright {dot} org